PERSPECTA

News from every angle

Back to headlines

Big Pharma M&A Outpaces Biotech IPOs, JPMorgan Says

JPMorgan bankers report that mergers and acquisitions in the pharmaceutical sector continue to outpace initial public offerings in the biotechnology industry.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.